Sutro Biopharma Regains Nasdaq Listing Compliance
at www.tipranks.com (Wed, 17-Dec 5:02 PM)
Sutro Biopharma’s Promising Phase 1 Study on STRO-004: A Potential Game-Changer in Cancer Treatment
at www.tipranks.com (Sun, 14-Dec 11:39 AM)
Sutro Biopharma Advances STRO-004 with First Patients Dosed in Pioneering Phase 1 Study
Market Chameleon (Thu, 4-Dec 10:03 AM)
